Osteoporosis is an important and common complex health problem, particularly in postmenopausal women. It is characterized by a reduction in bone mineral density (BMD) and a deterioration of bone microarchitecture with a consequent increase of fracture risk. The osteoprotegerin (OPG) gene is considered to play an important role in the pathogenesis of osteoporosis. We analyzed SNPs of the OPG gene and associations between these polymorphisms and BMD in 399 Chinese postmenopausal women. BMD was quantified at the lumbar spine (L 2-4 ), femoral neck, and total hip. The g.2264T>C and g.27676A>C SNPs were detected by PCR-RFLP and DNA sequencing methods. A significant association with spine BMD was found for g.27676A>C. The spine BMD value for subjects with genotype AA was significantly higher than those with genotypes GA and AA. No significant association was detected between any of the SNP marker genotypes and the other traits. We conclude that g.27676A>C in the OPG gene affects spine BMD and that the C allele is associated with increased risk for osteoporosis in Chinese postmenopausal women.
INTRODUCTION
Osteoporosis, a common complex and polygenic health problem of the postmenopausal women, is a skeletal disorder characterized by a reduction in bone mineral density (BMD) and a microarchitectural deterioration of bone tissue with a consequent increase in fracture risk (Cummings et al., 1985; Riggs and Melton, 1986, Peck, 1993; Kanis et al., 1994; Geng et al., 2007; Garcia-Unzueta et al., 2008) . BMD is a complex trait that is influenced by multiple genes and environmental factors (Ohmori et al., 2002) . Genetic factors play an important role in the pathogenesis of osteoporosis (Albagha and Ralston, 2006; Ferrari, 2008; Cheung et al., 2010; Hosoi, 2010; Ralston, 2010) . Several genes have been found to be involved in bone mineral homeostasis, bone remodeling, and bone matrix composition, e.g., osteoprotegerin (OPG) (Pocock et al., 1987; Hofbauer and Schoppet, 2002; Langdahl et al., 2002; Yamada et al., 2003; Arko et al., 2002 Arko et al., , 2005 Vidal et al., 2011) , estrogen receptor (Ioannidis et al., 2002 (Ioannidis et al., , 2004 Gennari et al., 2005) , vitamin D receptor (Fang et al., 2005; Li et al., 2012) , transforming growth factor b1 (Yamada, 2001) , and collagen type 1a1 (Mann and Ralston, 2003) . OPG has been considered an important candidate gene for osteoporosis, as polymorphisms in OPG may contribute to a genetic influence on BMD (Pocock et al., 1987; Hofbauer and Schoppet, 2002; Langdahl et al., 2002; Yamada et al., 2003; Arko et al., 2002 Arko et al., , 2005 Vidal et al., 2011) . Association analyses between OPG polymorphisms and BMD have been performed in osteoporosis, e.g., A163G, T245G, T950C, and G1181C (Arko et al., 2002; Langdahl et al., 2002; Ohmori et al., 2002; Jorgensen et al., 2004; Zhao et al., 2005; Kim et al., 2007; Ueland et al., 2007; Garcia-Unzueta et al., 2008; Moffett et al., 2008; Lee et al., 2010) , but there have been no published results about the association between the g.2264T>C and g.27676A>C polymorphisms of the OPG gene and BMD in various subjects. Therefore, the objective of this study was to investigate the g.2264 T>C and g.27676A>C polymorphisms of the OPG gene and to evaluate their effect on BMD in Chinese women.
MATERIAL AND METHODS

Subjects
The study included 399 postmenopausal women, where 247 were primary postmenopausal osteoporosis patients (aged 49-80 years) and 152 were healthy volunteers (aged 48-81 years). Subjects suffering from diseases or taking drugs that could affect bone metabolism were excluded. All subjects were genetically unrelated ethnic Han Chinese. This study was approved by the local Ethics Committee, and informed consent was obtained from all participants.
Measurement of bone mineral density
BMD of the lumbar spine (L 2-4 ), femoral neck, and total hip was assessed using dualenergy X-ray absorptiometry (Lunar Expert 1313, Lunar Corp., USA). BMD was automatically calculated from the bone mineral content (g) and bone area (cm 2 ) and expressed absolutely in g/cm 2 .
Genotyping test
Genomic DNA was isolated from peripheral venous blood samples according to the standard phenol/chloroform/isoamyl alcohol extraction protocol and stored at -20°C until analyzed. Based on the DNA sequences (GenBank ID: NG_012202.1) and mRNA sequences (GenBank ID: NM_002546.3) of the human OPG gene, 2 pairs of primers were designed using the Primer Premier 5.0 software (Premier Biosoft International, Palo Alto, CA, USA) to amplify and verify candidate SNPs (Table 1) . Primer sequences, annealing temperature, region, fragment sizes, and selected restriction enzymes are shown in Table 1 . Polymerase chain reaction (PCR) amplifications were performed in a 20-μL reaction mixture containing 50 ng mixed DNA template, 10 pM each primer, 0.20 mM dNTPs, 2.5 mM MgCl 2 , and 0.5 U Taq DNA polymerase (TaKaRa, Dalian, China). The PCR protocol was 95°C for 5 min followed by 32 cycles of 94°C for 30 s, annealing at the corresponding temperature (shown in Table 1 ) for 30 s, and 72°C for 30 s, with a final extension at 72°C for 10 min. The PCR products were separated on a 1.5% agarose gel (Promega) including 0.5 µg/mL ethidium bromide. The g.2264T>C and g.27676A>C SNPs were genotyped by the PCR-restriction fragment length polymorphism (PCR-RFLP) method. Aliquots of 5 μL PCR products were digested with 2 U restriction enzyme at 37°C for 10 h following the supplier manual. The digested products were separated by electrophoresis for 1 h at 100 V on a 2.5% agarose gel stained with ethidium bromide in 1X TAE buffer. The genotype results of allelic variation were based on the electrophoretic pattern of the restriction enzyme-treated PCR products. The PCR-amplified products of each genotype were purified using a Wizard Prep PCR purification kit and were sequenced in both directions with an ABI 3730 sequencer (Bioasia Biotechnology Co., Ltd., Shanghai, China). : 219, 197, 22 CC: 197, 22 AT = annealing temperature; SAF = size of amplification fragment; RE = restriction enzyme; RES = size of fragments at the indicated allele after digestion of the PCR product using the respective restriction enzyme. 
Statistical analysis
Allelic and genotypic frequencies in the subjects studied were calculated and the Har-dy-Weinberg equilibrium of the mutation was determined by the chi-squared test. Quantitative data were compared by one-way ANOVA and the LSD post hoc test. Multiple regression and logistic regression analyses were carried out to evaluate the relationships between the variables. All data are reported as means ± SD. All statistical analyses were performed with the Statistical Package for Social Sciences software (SPSS, Windows version release 15.0; SPSS Inc., Chicago, IL, USA). P < 0.05 was considered to be statistically significant.
RESULTS
SNP identification and genotyping
In this study, the g.2264T>C and g.27676A>C SNPs were identified by PCR-RFLP and DNA sequencing methods, including T→C mutation at position 2264 and A→C mutation [resulting in phenylalanine (Phe) to valine (Val) amino acid replacement, p.Phe371Val] at position 27676 of the human OPG gene, respectively, in intron 1 and exon 5 (reference sequences NG_012202.1, NM_002546.3, and NP_002537.3). The PCR product of g.2264T>C was digested with NlaIII enzyme and divided into 3 genotypes, TT (216 bp), TC (216, 150, and 66 bp), and CC (150 and 66 bp) ( Table 1 ). The PCR product of g.27676 A>C was digested with the AvaII enzyme, and the 3 possible genotypes were defined by 3 distinct banding patterns: AA (219 bp), AB (219, 197, and 22 bp), and BB (197 and 22 bp) ( Table 1) .
Frequencies of allele and genotype
The allelic and genotypic frequencies of the g.2264T>C and g.27676A>C polymorphisms are shown in Table 2 . Allele T and allele A were predominant alleles, and the genotype TT and AA frequencies were the highest in the subjects studied, respectively, in g.2264T>C (Table 2 ) and g.27676A>C (Table 3 ). The result of the chi-squared test for g.2264T>C and g.27676A>C in the populations studied indicated that the polymorphism sites were in HardyWeinberg equilibrium (P > 0.05). Table 2 . Genotypic and allelic frequencies of the OPG gene g.2264T>C polymorphism in the groups studied. Table 3 . Genotypic and allelic frequencies of the OPG gene g.27676A>C polymorphism in the groups studied.
Association of OPG gene polymorphisms with BMD
Age, weight, height, body mass index, spine BMD, femoral neck hip BMD, and total hip BMD in each genotype group were given as means ± SD (Tables 4 and 5 ). The gene-specific SNP marker association analysis indicated a significant association of g.27676A>C with spine BMD. The spine BMD of subjects with genotype AA was significantly higher than that of genotypes GA and AA (Table 5 ). However, no significant association was detected between any of the SNP marker genotypes and other traits measured in this study (Tables 4 and 5 ). 
DISCUSSION
In the present study, we investigated the role of OPG in the pathogenesis of osteoporosis by association analysis. The results showed that the g.27676A>C SNP polymorphism in exon 5 was associated with spine BMD in women. Subjects with genotype AA had significantly higher BMD compared to genotypes AC and CC (Table 5 , P = 0.041), and the AA genotype had a higher femoral neck hip BMD and total hip BMD than genotypes AC and CC, almost reaching a significant level (Table 4 , P = 0.065 and P = 0.069). The C allele could be a risk factor for osteoporosis in Chinese postmenopausal women. As for g.2264T>C SNP in intron 2, the TT genotype had a higher spine BMD, femoral neck hip BMD, and total hip BMD than genotypes TC and CC, almost reaching a significant level (Table 4 , P = 0.053, P = 0.061, and P = 0.072, respectively). Although introns are not coding sequences, there is constant evidence to prove that introns play an important role in regulating mRNA splicing, transcription, and gene expression and regulation (Nott et al., 2003; Zheng et al., 2011; Yuan et al., 2012) .
Whether the detected g.2264T>C locus in the OPG gene intron 6 affects gene expression and regulation needs to be determined. Previous studies have found an association between several SNPs and BMD, e.g., A163G, T245G, T950C, and G1181C, which is consistent with our findings that polymorphisms in the OPG gene may contribute to a genetic influence on BMD in osteoporosis (Arko et al., 2002; Langdahl et al., 2002; Ohmori et al., 2002; Jorgensen et al., 2004; Zhao et al., 2005; Kim et al., 2007; Ueland et al., 2007; Garcia-Unzueta et al., 2008; Moffett et al., 2008; Lee et al., 2010) . How these polymorphisms affect BMD still remains poorly understood. Further studies are necessary to elucidate the underlying molecular mechanism and pathophysiology.
